PAR 4.44% 21.5¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview, page-15

  1. 2,957 Posts.
    lightbulb Created with Sketch. 624
    Alas I think what we will see is anything but steady and reassuring.....market is a forward looking beast. In 2024 on successful P3 this will be $10-$15 plus....unless a deal is done prior which is likely so you might as well assume $15- $30 plus. Now that is just the starting plate for this stock if we retain control ( not likely ? ) and that is where all the money will come from to power the rise.

    So 2024?.....retrace to 2022 and we may see that sort of number then - why? I am not sure....but the market just seems to work this way - no free lunches - got to pick it 2 years out to get the payday. There will be no press release/ no asx ann but they will know...early on...that the results are matching P2 and SAS...The odds of success here are so high it will just be a numbers and time game and no way are we waiting till 2024 for the fun to start. Some zig zag chart line of some crazy hard to predict sort has to get us through 2021 with our shirts intact coz there will be plenty of action while the big boys get all set up for 2022.

    or of course we could track sideways and in 2024 on read out we will go up to whatever price? no chance thats how it's going to play imo.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
-0.010(4.44%)
Mkt cap ! $77.86M
Open High Low Value Volume
23.0¢ 23.0¢ 21.5¢ $60.42K 270.9K

Buyers (Bids)

No. Vol. Price($)
11 205897 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 6245 2
View Market Depth
Last trade - 12.34pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.